We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GPhA Analysis Says PhRMA Study on Authorized Generics "Filled With Errors"
GPhA Analysis Says PhRMA Study on Authorized Generics "Filled With Errors"
July 31, 2006
The Generic Pharmaceutical Association (GPhA) issued a study July 31 that shows the long-term effect of allowing brand drug companies to launch an authorized generic during a generic firm’s 180-day exclusivity period will be decreased competition and reduced access to cheaper drugs.